CBD’s GRAS status denied: FDA emits further warnings on compound’s legality amid safety concerns

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

A new Gencor study is touting its Levagen+ product, which contains palmitoylethanolamide (PEA), is a viable alternative to cannabidiol (CBD) – offering the same... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The US Food and Drug Administration (FDA) no longer intends to object to the use of certain qualified health claims regarding the consumption of magnesium and a reduced... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

This week in nutrition news, Evolva has secured up to US$13 million in financing from Nice & Green, while the debate over the use of N-acetyl-L-cysteine (NAC) in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A public comment made to the US Food and Drug Administration (FDA) over its “Closer to Zero” action plan, which aims to reduce heavy metals in baby food, has... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Australia-based Elixinol Wellness will be bringing its cannabidiol (CBD) supplements and cosmetics to the UK after partnering with British Cannabis. The move comes after... Read More

trans